Traci L Bricker
Overview
Explore the profile of Traci L Bricker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Soudani N, Bricker T, Darling T, Seehra K, Patel N, Guebre-Xabier M, et al.
J Virol
. 2024 Sep;
98(10):e0052824.
PMID: 39230305
Importance: As SARS-CoV-2 continues to evolve, there is a need to assess the immunogenicity and efficacy of updated vaccines against newly emerging variants in pre-clinical models such as mice and...
2.
Darling T, Harastani H, Joshi A, Bricker T, Soudani N, Seehra K, et al.
Sci Adv
. 2024 Jul;
10(31):eadp1290.
PMID: 39083604
COVID-19 vaccines have successfully reduced severe disease and death after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nonetheless, COVID-19 vaccines are variably effective in preventing transmission and symptomatic SARS-CoV-2...
3.
Boon A, Bricker T, Fritch E, Leist S, Gully K, Baric R, et al.
J Virol
. 2024 Apr;
98(5):e0190323.
PMID: 38593045
Importance: SARS-CoV-2 and other emerging RNA coronaviruses are a present and future threat in causing widespread endemic and pandemic infection and disease. In this paper, we have shown that the...
4.
Boon A, Bricker T, Fritch E, Leist S, Gully K, Baric R, et al.
bioRxiv
. 2024 Feb;
PMID: 38405752
Importance: SARS-CoV-2 and other emerging RNA coronaviruses are a present and future threat in causing widespread endemic and pandemic infection and disease. In this paper, we have shown that the...
5.
Bricker T, Joshi A, Soudani N, Scheaffer S, Patel N, Guebre-Xabier M, et al.
J Virol
. 2024 Feb;
98(3):e0120623.
PMID: 38305154
Importance: As SARS-CoV-2 continues to evolve, there may be a need to update the vaccines to match the newly emerging variants. Here, we compared the protective efficacy of the updated...
6.
Case J, Scheaffer S, Darling T, Bricker T, Adams L, Harastani H, et al.
J Virol
. 2023 Sep;
97(9):e0062823.
PMID: 37676002
The continued evolution and emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have resulted in challenges to vaccine and antibody efficacy. The emergence of each new variant...
7.
Ghumra D, Shetty N, McBrearty K, Puthussery J, Sumlin B, Gardiner W, et al.
ACS Sens
. 2023 Jul;
8(8):3023-3031.
PMID: 37498298
Airborne transmission via virus-laden aerosols is a dominant route for the transmission of respiratory diseases, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Direct, non-invasive screening of respiratory virus aerosols...
8.
Puthussery J, Ghumra D, McBrearty K, Doherty B, Sumlin B, Sarabandi A, et al.
Nat Commun
. 2023 Jul;
14(1):3692.
PMID: 37429842
Real-time surveillance of airborne SARS-CoV-2 virus is a technological gap that has eluded the scientific community since the beginning of the COVID-19 pandemic. Offline air sampling techniques for SARS-CoV-2 detection...
9.
Jiang H, Joshi A, Gan T, Janowski A, Fujii C, Bricker T, et al.
J Virol
. 2023 May;
97(6):e0063523.
PMID: 37223945
The stem-loop II motif (s2m) is an RNA structural element that is found in the 3' untranslated region (UTR) of many RNA viruses, including severe acute respiratory syndrome coronavirus 2...
10.
Case J, Scheaffer S, Darling T, Bricker T, Adams L, Harastani H, et al.
bioRxiv
. 2023 May;
PMID: 37205409
Importance: As SARS-CoV-2 continues to evolve, there is a need to rapidly assess the efficacy of vaccines and antiviral therapeutics against newly emergent variants. To do so, the commonly used...